Palo Alto, CA, United States of America

Lianfa Li

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 85(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2009 - 2016)
  • San Jose, CA (US) (2014 - 2020)

Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Achievements of Lianfa Li in Pharmaceutical Patents

Introduction

Lianfa Li, an accomplished inventor based in Palo Alto, California, has made significant contributions to the field of pharmaceuticals with a total of 16 patents under his name. His work focuses primarily on developing compounds that target specific receptors, bringing new hope to the treatment of various medical conditions.

Latest Patents

Among his latest innovations, Lianfa Li has patented compounds known as Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides. These compounds serve as potent antagonists of the CCR(9) receptor, which has been identified as a key player in inflammation, a hallmark disease associated with CCR(9). The animal testing results indicate that these compounds are not only effective for treating CCR(9)-mediated diseases but also valuable as controls in assays for the identification of CCR(9) antagonists. This dual functionality highlights the significance of his research in both therapeutic applications and scientific discovery.

Career Highlights

Lianfa Li's career at Chemocentryx, Inc. has positioned him as a prominent figure in the pharmaceutical industry. His dedication to innovation has brought forth advancements that could transform treatment protocols for inflammation-related diseases. The combination of his expertise and the resources available within Chemocentryx, Inc. has allowed him to drive impactful research initiatives.

Collaborations

Throughout his career, Lianfa Li has collaborated with talented coworkers, including Penglie Zhang and Andrew M. K. Pennell. These partnerships exemplify the collaborative nature of scientific research, as each individual brings unique expertise that contributes to innovative breakthroughs in the development of new compounds.

Conclusion

Lianfa Li’s contributions to the field of pharmaceuticals, particularly through his recent patents, underscore his importance as an inventor and innovator. With a focus on addressing critical medical issues like inflammation, his work not only exemplifies the capabilities of modern scientific research but also sets the stage for future advancements in drug development. The ongoing innovations at Chemocentryx, Inc. will likely continue to enhance our understanding and treatment of complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…